Anson Funds Management LP - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 2 filers reported holding CLEVELAND BIOLABS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Anson Funds Management LP ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2014$164,000575,4550.19%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q1 2015
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 640,700$750,0000.14%
GOODNOW INVESTMENT GROUP, LLC 560,461$656,0000.11%
LADENBURG THALMANN FINANCIAL SERVICES INC. 752,038$999,0000.03%
Winfield Associates, Inc. 15,711$18,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 157,249$184,0000.01%
Van Cleef Asset Management,Inc 20,000$23,0000.01%
ACG Wealth 31,600$37,0000.01%
KINGS POINT CAPITAL MANAGEMENT 10,000$12,0000.00%
TAURUS ASSET MANAGEMENT, LLC 15,000$18,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 115,249$135,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders